DK1097148T3 - Ritonavir-polymorf - Google Patents

Ritonavir-polymorf

Info

Publication number
DK1097148T3
DK1097148T3 DK99934143T DK99934143T DK1097148T3 DK 1097148 T3 DK1097148 T3 DK 1097148T3 DK 99934143 T DK99934143 T DK 99934143T DK 99934143 T DK99934143 T DK 99934143T DK 1097148 T3 DK1097148 T3 DK 1097148T3
Authority
DK
Denmark
Prior art keywords
ritonavir polymorph
ritonavir
polymorph
Prior art date
Application number
DK99934143T
Other languages
Danish (da)
English (en)
Inventor
John F Bauer
Azita Saleki-Gerhardt
Bikshandarkoil A Narayanan
Sanjay R Chemburkar
Ketan Patel
Harry O Spiwek
Philip E Bauer
Kimberly A Allen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26817251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1097148(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1097148T3 publication Critical patent/DK1097148T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK99934143T 1998-07-20 1999-07-19 Ritonavir-polymorf DK1097148T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11934598A 1998-07-20 1998-07-20
US32609399A 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
DK1097148T3 true DK1097148T3 (da) 2004-04-26

Family

ID=26817251

Family Applications (3)

Application Number Title Priority Date Filing Date
DK99934143T DK1097148T3 (da) 1998-07-20 1999-07-19 Ritonavir-polymorf
DK03029709T DK1418174T3 (da) 1998-07-20 1999-07-19 Amorf ritonavir
DK08007622T DK2017269T3 (da) 1998-07-20 1999-07-19 Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK03029709T DK1418174T3 (da) 1998-07-20 1999-07-19 Amorf ritonavir
DK08007622T DK2017269T3 (da) 1998-07-20 1999-07-19 Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf

Country Status (29)

Country Link
EP (4) EP1418174B1 (cs)
JP (4) JP4815050B2 (cs)
KR (3) KR100740796B1 (cs)
CN (5) CN102153524A (cs)
AR (5) AR019431A1 (cs)
AT (3) ATE425974T1 (cs)
AU (1) AU768207B2 (cs)
BG (4) BG65150B1 (cs)
BR (1) BR9912010A (cs)
CA (3) CA2510949C (cs)
CO (1) CO5090830A1 (cs)
CY (2) CY1111600T1 (cs)
CZ (2) CZ298188B6 (cs)
DE (2) DE69940616D1 (cs)
DK (3) DK1097148T3 (cs)
ES (3) ES2372990T3 (cs)
HU (3) HU229999B1 (cs)
ID (1) ID27996A (cs)
IL (4) IL140492A0 (cs)
MY (2) MY121765A (cs)
NO (2) NO318385B1 (cs)
NZ (2) NZ509125A (cs)
PL (2) PL194710B1 (cs)
PT (3) PT1097148E (cs)
SI (3) SI2017269T1 (cs)
SK (3) SK287381B6 (cs)
TR (1) TR200100171T2 (cs)
TW (3) TWI227713B (cs)
WO (1) WO2000004016A2 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
MY121765A (en) * 1998-07-20 2006-02-28 Abbott Lab Polymorph of ritonavir
CN101361723B (zh) * 1999-06-04 2013-11-06 Abbvie公司 改进的药物制剂
WO2002096395A1 (en) * 2001-05-25 2002-12-05 Abbott Laboratories Soft elastic capsules comprising ritonavir and/or lopinavir
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
US7205413B2 (en) 2002-05-03 2007-04-17 Transform Pharmaceuticals, Inc. Solvates and polymorphs of ritonavir and methods of making and using the same
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
BRPI0401742B8 (pt) 2004-05-13 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir
WO2006129276A1 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Processes for the preparation of stable polymorphic form i of ritonavir
WO2008041176A2 (en) * 2006-10-03 2008-04-10 Ranbaxy Laboratories Limited Process for the preparation of form i and form ii of ritonavir
CN102898398B (zh) * 2011-07-27 2015-01-14 上海迪赛诺药业有限公司 一种制备i型利托那韦多晶型结晶的方法
WO2013131646A1 (en) 2012-03-07 2013-09-12 Ratiopharm Gmbh Dosage form comprising lopinavir and ritonavir
US20150111909A1 (en) 2012-03-07 2015-04-23 Ratiopharm Gmbh Dosage form comprising non-crystalline lopinavir and crystalline ritonavir
HK1220390A1 (zh) 2013-08-29 2017-05-05 Teva Pharmaceutical Industries Ltd. 包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
EP3129009A1 (en) 2014-04-08 2017-02-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN106749085B (zh) * 2016-12-23 2019-05-24 东北制药集团股份有限公司 一种制备利托那韦的方法
EP3569225A1 (en) 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Solid dispersion containing ritonavir
RU2759544C1 (ru) * 2021-01-29 2021-11-15 Общество с ограниченной ответственностью "АМЕДАРТ" Твёрдая фармацевтическая композиция для изготовления перорального терапевтического средства для профилактики и/или лечения ВИЧ-инфекции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696270A (en) * 1989-05-23 1997-12-09 Abbott Laboratories Intermediate for making retroviral protease inhibiting compounds
US5354866A (en) 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
ATE143262T1 (de) * 1992-12-29 1996-10-15 Abbott Lab Inhibitoren der retroviralen protease
IL110752A (en) 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
US5491253A (en) 1993-10-22 1996-02-13 Abbott Laboratories Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
IL111991A (en) 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US5567823A (en) * 1995-06-06 1996-10-22 Abbott Laboratories Process for the preparation of an HIV protease inhibiting compound
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6160122A (en) 1996-06-28 2000-12-12 Abbott Laboratories Process for the preparation of a disubstituted thiazole
ZA9710071B (en) 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY121765A (en) * 1998-07-20 2006-02-28 Abbott Lab Polymorph of ritonavir
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
CN101361723B (zh) * 1999-06-04 2013-11-06 Abbvie公司 改进的药物制剂

Also Published As

Publication number Publication date
IL191582A (en) 2016-02-29
KR20060118022A (ko) 2006-11-17
NO327320B1 (no) 2009-06-08
SK287586B6 (sk) 2011-03-04
CZ298188B6 (cs) 2007-07-18
KR20040081137A (ko) 2004-09-20
CZ307116B6 (cs) 2018-01-24
BG109682A (bg) 2007-03-30
EP2017269B1 (en) 2011-11-23
PT2017269E (pt) 2011-12-20
TWI271400B (en) 2007-01-21
IL191582A0 (en) 2008-12-29
DE69915628D1 (en) 2004-04-22
CA2510949C (en) 2009-11-17
JP4815050B2 (ja) 2011-11-16
EP2017269A3 (en) 2009-06-10
KR20010072003A (ko) 2001-07-31
TW200716550A (en) 2007-05-01
SI1418174T1 (sl) 2009-08-31
EP1097148A2 (en) 2001-05-09
NO318385B1 (no) 2005-03-14
CN101259128A (zh) 2008-09-10
IL187181A (en) 2009-09-01
EP2017269A8 (en) 2009-09-30
EP2017269A9 (en) 2009-10-14
PL348033A1 (en) 2002-05-06
CN1310715A (zh) 2001-08-29
WO2000004016A2 (en) 2000-01-27
SK286388B6 (sk) 2008-09-05
HU229999B1 (en) 2015-04-28
DE69940616D1 (de) 2009-04-30
MY145265A (en) 2012-01-13
EP1097148B1 (en) 2004-03-17
SI2017269T1 (sl) 2012-02-29
TR200100171T2 (tr) 2001-05-21
AR044029A2 (es) 2005-08-24
HU230150B1 (hu) 2015-09-28
EP2298751A2 (en) 2011-03-23
JP2014074047A (ja) 2014-04-24
AR059764A2 (es) 2008-04-30
AR059763A2 (es) 2008-04-30
HUP0103823A2 (hu) 2002-02-28
CN102153524A (zh) 2011-08-17
ATE534636T1 (de) 2011-12-15
ATE425974T1 (de) 2009-04-15
BG105197A (en) 2001-10-31
SI1097148T1 (en) 2004-10-31
ES2372990T3 (es) 2012-01-30
CO5090830A1 (es) 2001-10-30
CY1112139T1 (el) 2015-11-04
HK1121155A1 (en) 2009-04-17
WO2000004016A3 (en) 2000-03-30
AR049658A2 (es) 2006-08-23
CA2337846C (en) 2006-02-21
SK922001A3 (en) 2001-07-10
NZ522690A (en) 2004-04-30
EP2017269A2 (en) 2009-01-21
HU0800266D0 (en) 2008-06-30
HU227540B1 (en) 2011-08-29
PL194710B1 (pl) 2007-06-29
HK1037918A1 (en) 2002-02-22
EP2298751A3 (en) 2011-08-17
CN101966180A (zh) 2011-02-09
KR100793046B1 (ko) 2008-01-10
IL187181A0 (en) 2008-02-09
CA2337846A1 (en) 2000-01-27
BG65963B1 (bg) 2010-07-30
NO20010298D0 (no) 2001-01-18
BG66140B1 (bg) 2011-07-29
IL140492A0 (en) 2002-02-10
JP5732212B2 (ja) 2015-06-10
DE69915628T2 (de) 2004-08-12
AR019431A1 (es) 2002-02-20
ATE261947T1 (de) 2004-04-15
PT1418174E (pt) 2009-06-08
NZ509125A (en) 2003-02-28
NO20010298L (no) 2001-01-18
CN1310715B (zh) 2010-11-03
EP1418174A2 (en) 2004-05-12
IL140492A (en) 2010-12-30
JP2002520410A (ja) 2002-07-09
SK287381B6 (sk) 2010-08-09
BG110080A (bg) 2008-11-28
EP1418174B1 (en) 2009-03-18
ID27996A (id) 2001-05-03
CY1111600T1 (el) 2015-10-07
BR9912010A (pt) 2001-04-10
JP2017061475A (ja) 2017-03-30
PT1097148E (pt) 2004-05-31
KR100853371B1 (ko) 2008-08-22
PL213978B1 (pl) 2013-05-31
CA2510949A1 (en) 2000-01-27
HU0800267D0 (en) 2008-06-30
NO20042393L (no) 2001-01-18
CA2674800A1 (en) 2000-01-27
HUP0103823A3 (en) 2003-05-28
AU5003799A (en) 2000-02-07
CZ2001203A3 (en) 2001-05-16
KR100740796B1 (ko) 2007-07-20
BG65150B1 (bg) 2007-04-30
MY121765A (en) 2006-02-28
CZ2006533A3 (cs) 2001-05-16
EP1418174A3 (en) 2004-06-23
TWI362382B (en) 2012-04-21
CN1502613A (zh) 2004-06-09
AU768207B2 (en) 2003-12-04
TWI227713B (en) 2005-02-11
DK2017269T3 (da) 2012-03-05
ES2322759T3 (es) 2009-06-26
ES2214038T3 (es) 2004-09-01
DK1418174T3 (da) 2009-05-18
JP2010270135A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
NO20010193L (no) Tiobenzimidazol-derivater
ATE236136T1 (de) Benzosulfonderivate
NO20010514L (no) Aminometylkarboksylsyre-derivater
ATE259810T1 (de) Phenyl-xanthinderivate
DK0928790T3 (da) Thiazolderivater
DK1097148T3 (da) Ritonavir-polymorf
ATE262513T1 (de) Benzoylpyridazine
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de) Chromanderivate
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DK1060183T3 (da) 5-deoxycytidinderivater
DE59808995D1 (de) Endomikroskopsystem
DE59807217D1 (de) Nadellager
DK1123283T3 (da) Thiazolderivater
DE19842103B4 (de) Stanznietzuführung
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DK0928793T3 (da) Thiazolderivater
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate
FR2784735B1 (fr) Raccord tournant
DE69901485D1 (de) Doppelfunktions-strukturen
ATA126298A (de) Verpuffungsklappe
DE59900975D1 (de) Falzwalzenlagerung
KR980004845U (ko) 타이거